Navigation Links
Immucor to Announce Fiscal First Quarter Financial Results on Thursday, October 1, 2009
Date:9/17/2009

NORCROSS, Ga., Sept. 17 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it will release its fiscal 2010 first quarter earnings on Thursday, October 1, 2009 after the market close. The Company will host a conference call on Friday, October 2, 2009 at 8:30 a.m. (Eastern Time) to discuss the results.

Investors are invited to participate in this conference call by dialing 1-888-324-9321 (Passcode: BLUD). Investors can also access the call via Webcast through the "About Us - Investor Information" section at www.immucor.com. A copy of the press release will be available at the same Web address.

For those unable to listen to the live broadcast, a replay of the conference call will be available shortly after its completion and will be archived on Immucor's website for approximately 60 days. Additionally, investors may access a replay of the call for one week beginning at noon on October 2nd by dialing 1-866-403-7112 (Passcode: 2583).

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.


'/>"/>
SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Immucor to Present at Upcoming Investor Conferences
2. Immucor Announces Fiscal Fourth Quarter Results
3. Immucor Appoints Chief Operating Officer
4. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
5. Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009
6. Immucor Announces Fiscal Year 2010 Guidance
7. Immucor to Announce Fiscal 2010 Guidance on Monday, June 1, 2009
8. Immucor to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
9. Immucor Receives Subpoena From Department of Justice
10. Immucor Announces Fiscal Third Quarter Results
11. Immucor Announces New Vice President, Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 ... ... Company, Cal Dining at the University of California Berkeley, and other leading institutions ... leverages the buying power of institutions to change the way animals are raised ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: